REFERENCES
- Spitler LD, Wymer WW Jr. Physician's perceptions and uses of commercial drug information sources: An examination of pharmaceutical marketing to physicians. Health Mark Q. 2001; 19:91–106.
- Majia R, Avalos A. Printed material distributed by pharmaceutical propaganda agents. Medicine (B Aires). 2001; 61:315–18.
- Lal A. Pharmaceutical drug promotion: How is it being practiced in India? J Assoc Phys India. 2001; 49:266–73.
- Strang D, Gagnon M, Molloy W, et al. National survey on the attitudes of Cana-dian physicians towards drug-detailing by pharmaceutical representatives. Ann R Coll Phys Surg Can. 1996; 29:474–8.
- Vitry A. And next: A flask of wine for Daddy? Aust Prescr. 2003; 26:102.
- Promoting health in developing countries? Parke Davis offers free wine with Sinutab in fever. Worst Pills Best Pills News. 1995; 1:3–4.
- De Las Curvas C, Sanz EJ, De La Fuente JA. Variations in antidepressant pre-scribing practice: Clinical need or market influence? Pharmacoepidemiol Drug Saf 2002; 11:515–22.
- Quim RJ, O'Neill C. Attitudes of general practitioners to their interactions with pharmaceutical companies: A qualitative study. Ir Med J. 2002; 95:1999–2002.
- Gaedeke RM, Tootelian DH, Sanders EE. Value of services provided by phar-maceutical companies: Perceptions of physicians and pharmaceutical sales representa-tives. Health Mark Q. 1999;17:23–31.
- Wilkes MS, Hoffman JR. An innovative approach to educating medical students about pharmaceutical promotion. Acad Med. 2001; 76:1271–7.
- Henry D, Lexchin J. The pharmaceutical industry as a medicine provider. Lan-cet. 2002; 360:1590–5.
- McGettigan P, Golder J, Fryer J, Chan R, Feely J. Prescribers prefer people: The sources of information used by doctors for prescribing suggest that the medium is more important than the message. Br J Clin Pharmacol. 2001; 51:184–9.
- Guldal D, Semin S. The influence of drug companies' advertising programs on physicians. Int J Health Serv. 2000;30:585–95.
- Barros JA. (Mis)information on drugs: The double standard practiced by phar-maceutical companies. Cad Saude Publica. 2000; 16:421–7.
- Castillo Perez P. Poor promotional practices in pharmaceutical communication: The anti-medical visit, international experience. An Med Interna. 1993; 10:248–56.
- Peppin JF. Pharmaceutical sales representatives and physicians: Ethical consid-erations of a relationship. J Med Philos. 1996; 21:83–99.
- Anon. Code of ethics [editorial]. Pharma Pulse. 2002; (Jun 13). Available at: www.expresspharmapulse.com/20020613/editl.shtml.